Contract V797P2113D
Lupin Pharmaceuticals, Inc · Department Of Veterans Affairs · September 3, 2021
Lupin Pharmaceuticals, Inc was awarded a federal contract by Department Of Veterans Affairs on September 3, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 17, 2021. If all options are exercised, the contract could reach $45.00 million.
Contract details
- PIID
- V797P2113D
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 3, 2021
- Latest action
- September 17, 2021
Description
65IB: PRODUCT DELETION - DISCONTINUED BY THE MANUFACTURER
Modification timeline
-
September 17, 2021Mod P00042 · Supplemental Agreement For Work Within Scope$0
-
September 3, 2021Mod P00041 · Other Administrative ActionADMINISTRATIVE CHANGES - CONTACT/ALTERNATE CONTACT FOR CONTRACT ADMINISTRATION & CONTACT FOR SALES ADMINISTRATION CHANGES$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797P2113D?
Contract V797P2113D is a federal contract awarded to Lupin Pharmaceuticals, Inc by Department Of Veterans Affairs on September 3, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract V797P2113D?
Lupin Pharmaceuticals, Inc won contract V797P2113D from Department Of Veterans Affairs.
How much is contract V797P2113D worth?
Contract V797P2113D has obligated $0 to date but carries a potential ceiling of $45.00 million if fully funded and all options are exercised.